The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

Our previous studies have demonstrated that sorafenib can promote the dissemination of hepatocellular carcinoma (HCC) through downregulation of HTATIP2, a suppressor of tumor growth and metastasis that is associated with inhibition of angiogenesis. Here, we investigated the predictive values of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Sun, Hui-Chuan, Wu, Chun-Tao, Zhu, Xiao-Dong, Zhang, Wei, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Tang, Zhao-You, Yu, Xian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116529/
https://www.ncbi.nlm.nih.gov/pubmed/25008315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116529/
https://www.ncbi.nlm.nih.gov/pubmed/25008315

Ejemplares similares